Status:
UNKNOWN
Modified Versus Traditional Thoracic Drainage After Thoracoscopic Surgery
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Conditions:
Lung Neoplasms
Lung Cancer
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Lung cancer is the leading cause of cancer-related death worldwide. Thoracoscopic pulmonary resection is a prevalent management for early stage of lung cancer. Placement of traditional chest tube is t...
Eligibility Criteria
Inclusion
- 18\<age\<80;
- Patients with lung cancer;
- Thoracoscopic lung resection;
- Single chest-tube insertion.
Exclusion
- A history of preoperative chemotherapy or radiotherapy;
- Presence of distant tumor metastasis;
- Pneumonectomy;
- Dysfunction of cardiorespiratory system or other surgical contraindications.
Key Trial Info
Start Date :
December 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04309955
Start Date
December 1 2019
End Date
April 1 2020
Last Update
March 18 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Chongqing, Chongqing Municipality, China, 400042